Procedure
Standard exposure
Standard exposure is a medical procedure with 4 clinical trials. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
PROCEDURE
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 2 completed trials
Completion Rate
100%(2/2)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
Ph phase_2
1
25%
Ph not_applicable
3
75%
Phase Distribution
0
Early Stage
1
Mid Stage
0
Late Stage
Phase Distribution4 total trials
Phase 2Efficacy & side effects
1(25.0%)
N/ANon-phased studies
3(75.0%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
100.0%
2 of 2 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Completed(2)
Other(2)
Detailed Status
unknown2
Completed2
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
Phase 2
Trials by Phase
Phase 21 (25.0%)
N/A3 (75.0%)
Trials by Status
unknown250%
completed250%
Recent Activity
0 active trials
Showing 4 of 4
completednot_applicable
Exposure Therapy Consortium (ETC) for Anxiety Sensitivity
NCT05225740
completednot_applicable
Test of an Inhibitory Learning Model of Extinction in Treatment of Anxious Youth
NCT03372915
unknownnot_applicable
RSA for a Comparison of MIS vs. Standard Exposure in Total Hip Arthroplasty
NCT00405483
unknownphase_2
Comparison of Methods for the Delivery of Interoceptive Exposure
NCT01201304
Clinical Trials (4)
Showing 4 of 4 trials
NCT05225740Not Applicable
Exposure Therapy Consortium (ETC) for Anxiety Sensitivity
NCT03372915Not Applicable
Test of an Inhibitory Learning Model of Extinction in Treatment of Anxious Youth
NCT00405483Not Applicable
RSA for a Comparison of MIS vs. Standard Exposure in Total Hip Arthroplasty
NCT01201304Phase 2
Comparison of Methods for the Delivery of Interoceptive Exposure
All 4 trials loaded
Drug Details
- Intervention Type
- PROCEDURE
- Total Trials
- 4